================================================================================
BIOLOGICAL MODELING PIPELINE CONSISTENCY ANALYSIS
================================================================================
Generated: 2025-06-24 04:20:47

EXECUTIVE SUMMARY
--------------------------------------------------------------------------------
• Total experiment runs analyzed: 23
• Pipeline stages with data: 3

NATURAL LANGUAGE TO ONTOLOGY STAGE
===================================

CellOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 6
     • Average consistency: 18.3%
     • Maximum consistency: 40.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     40.0% [████░░░░░░] Endothelial Cell (CL:0000115)
     30.0% [███░░░░░░░] endothelial cell (CL:0000115)
     10.0% [█░░░░░░░░░] Endothelial (CL:0000115)
     10.0% [█░░░░░░░░░] Endothelial Progenitor Cell (CL:0002619)
     10.0% [█░░░░░░░░░] EndothelialCell (CL:0000115)
     ... and 1 more terms

  INCONSISTENT TERMS (< 50%):
     40.0% Endothelial Cell (CL:0000115)
     30.0% endothelial cell (CL:0000115)
     10.0% Endothelial (CL:0000115)
     ... and 3 more

GeneOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 18
     • Average consistency: 16.1%
     • Maximum consistency: 70.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     70.0% [███████░░░] Angiogenesis (GO:0001525)
     30.0% [███░░░░░░░] angiogenesis (GO:0001525)
     20.0% [██░░░░░░░░] negative regulation of angiogenesis (GO:0016525)
     20.0% [██░░░░░░░░] Blood Vessel Morphogenesis (GO:0048514)
     20.0% [██░░░░░░░░] BloodVesselDevelopment (GO:0001568)
     ... and 13 more terms

  INCONSISTENT TERMS (< 50%):
     30.0% angiogenesis (GO:0001525)
     20.0% negative regulation of angiogenesis (GO:0016525)
     20.0% Blood Vessel Morphogenesis (GO:0048514)
     ... and 14 more

MeSH Terms:
-----------
  STATISTICS:
     • Total unique terms: 23
     • Average consistency: 16.1%
     • Maximum consistency: 70.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     70.0% [███████░░░] Antineoplastic Agents (D000970)
     40.0% [████░░░░░░] Neovascularization, Pathologic (D018908)
     30.0% [███░░░░░░░] Neoplasms (D009369)
     20.0% [██░░░░░░░░] Angiogenesis Inhibitors (D019158)
     20.0% [██░░░░░░░░] Computer Simulation (D003198)
     ... and 18 more terms

  INCONSISTENT TERMS (< 50%):
     40.0% Neovascularization, Pathologic (D018908)
     30.0% Neoplasms (D009369)
     20.0% Angiogenesis Inhibitors (D019158)
     ... and 19 more

--------------------------------------------------------------------------------

ONTOLOGY TO CC3D CODE STAGE
============================

Code Similarity Analysis:
-------------------------
  STATISTICS:
     • Number of comparisons: 45
     • Average similarity: 7.3%
     • Minimum similarity: 1.3%
     • Maximum similarity: 19.5%

  OVERALL CODE CONSISTENCY: POOR

  PAIRWISE COMPARISONS:
     Runs 1-2: 5.6% [░░░░░░░░░░]
     Runs 1-3: 5.7% [░░░░░░░░░░]
     Runs 1-4: 2.3% [░░░░░░░░░░]
     Runs 1-5: 11.1% [█░░░░░░░░░]
     Runs 1-6: 3.6% [░░░░░░░░░░]
     Runs 1-7: 14.9% [█░░░░░░░░░]
     Runs 1-8: 5.6% [░░░░░░░░░░]
     Runs 1-9: 7.2% [░░░░░░░░░░]
     Runs 1-10: 6.1% [░░░░░░░░░░]
     Runs 2-3: 12.7% [█░░░░░░░░░]
     Runs 2-4: 6.4% [░░░░░░░░░░]
     Runs 2-5: 5.9% [░░░░░░░░░░]
     Runs 2-6: 9.6% [░░░░░░░░░░]
     Runs 2-7: 10.3% [█░░░░░░░░░]
     Runs 2-8: 5.4% [░░░░░░░░░░]
     Runs 2-9: 6.4% [░░░░░░░░░░]
     Runs 2-10: 6.5% [░░░░░░░░░░]
     Runs 3-4: 9.6% [░░░░░░░░░░]
     Runs 3-5: 4.5% [░░░░░░░░░░]
     Runs 3-6: 4.3% [░░░░░░░░░░]
     Runs 3-7: 8.9% [░░░░░░░░░░]
     Runs 3-8: 7.8% [░░░░░░░░░░]
     Runs 3-9: 6.1% [░░░░░░░░░░]
     Runs 3-10: 4.5% [░░░░░░░░░░]
     Runs 4-5: 3.2% [░░░░░░░░░░]
     Runs 4-6: 1.3% [░░░░░░░░░░]
     Runs 4-7: 2.1% [░░░░░░░░░░]
     Runs 4-8: 2.0% [░░░░░░░░░░]
     Runs 4-9: 10.3% [█░░░░░░░░░]
     Runs 4-10: 12.9% [█░░░░░░░░░]
     Runs 5-6: 11.7% [█░░░░░░░░░]
     Runs 5-7: 18.1% [█░░░░░░░░░]
     Runs 5-8: 19.5% [█░░░░░░░░░]
     Runs 5-9: 8.3% [░░░░░░░░░░]
     Runs 5-10: 4.7% [░░░░░░░░░░]
     Runs 6-7: 4.3% [░░░░░░░░░░]
     Runs 6-8: 6.1% [░░░░░░░░░░]
     Runs 6-9: 6.9% [░░░░░░░░░░]
     Runs 6-10: 3.7% [░░░░░░░░░░]
     Runs 7-8: 6.7% [░░░░░░░░░░]
     Runs 7-9: 5.8% [░░░░░░░░░░]
     Runs 7-10: 7.5% [░░░░░░░░░░]
     Runs 8-9: 6.1% [░░░░░░░░░░]
     Runs 8-10: 4.8% [░░░░░░░░░░]
     Runs 9-10: 9.3% [░░░░░░░░░░]

--------------------------------------------------------------------------------

NATURAL LANGUAGE TO CC3D CODE (END-TO-END) STAGE
=================================================

CellOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 6
     • Average consistency: 18.3%
     • Maximum consistency: 40.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     40.0% [████░░░░░░] Endothelial Cell (CL:0000115)
     30.0% [███░░░░░░░] endothelial cell (CL:0000115)
     10.0% [█░░░░░░░░░] Endothelial (CL:0000115)
     10.0% [█░░░░░░░░░] Endothelial Progenitor Cell (CL:0002619)
     10.0% [█░░░░░░░░░] EndothelialCell (CL:0000115)
     ... and 1 more terms

  INCONSISTENT TERMS (< 50%):
     40.0% Endothelial Cell (CL:0000115)
     30.0% endothelial cell (CL:0000115)
     10.0% Endothelial (CL:0000115)
     ... and 3 more

GeneOntology Terms:
-------------------
  STATISTICS:
     • Total unique terms: 18
     • Average consistency: 16.1%
     • Maximum consistency: 70.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     70.0% [███████░░░] Angiogenesis (GO:0001525)
     30.0% [███░░░░░░░] angiogenesis (GO:0001525)
     20.0% [██░░░░░░░░] negative regulation of angiogenesis (GO:0016525)
     20.0% [██░░░░░░░░] Blood Vessel Morphogenesis (GO:0048514)
     20.0% [██░░░░░░░░] BloodVesselDevelopment (GO:0001568)
     ... and 13 more terms

  INCONSISTENT TERMS (< 50%):
     30.0% angiogenesis (GO:0001525)
     20.0% negative regulation of angiogenesis (GO:0016525)
     20.0% Blood Vessel Morphogenesis (GO:0048514)
     ... and 14 more

MeSH Terms:
-----------
  STATISTICS:
     • Total unique terms: 23
     • Average consistency: 16.1%
     • Maximum consistency: 70.0%
     • Terms with 100% consistency: 0

  TOP CONSISTENT TERMS:
     70.0% [███████░░░] Antineoplastic Agents (D000970)
     40.0% [████░░░░░░] Neovascularization, Pathologic (D018908)
     30.0% [███░░░░░░░] Neoplasms (D009369)
     20.0% [██░░░░░░░░] Angiogenesis Inhibitors (D019158)
     20.0% [██░░░░░░░░] Computer Simulation (D003198)
     ... and 18 more terms

  INCONSISTENT TERMS (< 50%):
     40.0% Neovascularization, Pathologic (D018908)
     30.0% Neoplasms (D009369)
     20.0% Angiogenesis Inhibitors (D019158)
     ... and 19 more

Code Similarity Analysis:
-------------------------
  STATISTICS:
     • Number of comparisons: 45
     • Average similarity: 7.3%
     • Minimum similarity: 1.3%
     • Maximum similarity: 19.5%

  OVERALL CODE CONSISTENCY: POOR

  PAIRWISE COMPARISONS:
     Runs 1-2: 5.6% [░░░░░░░░░░]
     Runs 1-3: 5.7% [░░░░░░░░░░]
     Runs 1-4: 2.3% [░░░░░░░░░░]
     Runs 1-5: 11.1% [█░░░░░░░░░]
     Runs 1-6: 3.6% [░░░░░░░░░░]
     Runs 1-7: 14.9% [█░░░░░░░░░]
     Runs 1-8: 5.6% [░░░░░░░░░░]
     Runs 1-9: 7.2% [░░░░░░░░░░]
     Runs 1-10: 6.1% [░░░░░░░░░░]
     Runs 2-3: 12.7% [█░░░░░░░░░]
     Runs 2-4: 6.4% [░░░░░░░░░░]
     Runs 2-5: 5.9% [░░░░░░░░░░]
     Runs 2-6: 9.6% [░░░░░░░░░░]
     Runs 2-7: 10.3% [█░░░░░░░░░]
     Runs 2-8: 5.4% [░░░░░░░░░░]
     Runs 2-9: 6.4% [░░░░░░░░░░]
     Runs 2-10: 6.5% [░░░░░░░░░░]
     Runs 3-4: 9.6% [░░░░░░░░░░]
     Runs 3-5: 4.5% [░░░░░░░░░░]
     Runs 3-6: 4.3% [░░░░░░░░░░]
     Runs 3-7: 8.9% [░░░░░░░░░░]
     Runs 3-8: 7.8% [░░░░░░░░░░]
     Runs 3-9: 6.1% [░░░░░░░░░░]
     Runs 3-10: 4.5% [░░░░░░░░░░]
     Runs 4-5: 3.2% [░░░░░░░░░░]
     Runs 4-6: 1.3% [░░░░░░░░░░]
     Runs 4-7: 2.1% [░░░░░░░░░░]
     Runs 4-8: 2.0% [░░░░░░░░░░]
     Runs 4-9: 10.3% [█░░░░░░░░░]
     Runs 4-10: 12.9% [█░░░░░░░░░]
     Runs 5-6: 11.7% [█░░░░░░░░░]
     Runs 5-7: 18.1% [█░░░░░░░░░]
     Runs 5-8: 19.5% [█░░░░░░░░░]
     Runs 5-9: 8.3% [░░░░░░░░░░]
     Runs 5-10: 4.7% [░░░░░░░░░░]
     Runs 6-7: 4.3% [░░░░░░░░░░]
     Runs 6-8: 6.1% [░░░░░░░░░░]
     Runs 6-9: 6.9% [░░░░░░░░░░]
     Runs 6-10: 3.7% [░░░░░░░░░░]
     Runs 7-8: 6.7% [░░░░░░░░░░]
     Runs 7-9: 5.8% [░░░░░░░░░░]
     Runs 7-10: 7.5% [░░░░░░░░░░]
     Runs 8-9: 6.1% [░░░░░░░░░░]
     Runs 8-10: 4.8% [░░░░░░░░░░]
     Runs 9-10: 9.3% [░░░░░░░░░░]

--------------------------------------------------------------------------------

RECOMMENDATIONS & INSIGHTS
================================================================================
ONTOLOGY CONSISTENCY ISSUES:
   • CellOntology shows low consistency (18.3%) in natural_to_ontology
     → Consider refining prompts for CellOntology term extraction
   • GeneOntology shows low consistency (16.1%) in natural_to_ontology
     → Consider refining prompts for GeneOntology term extraction
   • MeSH shows low consistency (16.1%) in natural_to_ontology
     → Consider refining prompts for MeSH term extraction
   • CellOntology shows low consistency (18.3%) in natural_to_code
     → Consider refining prompts for CellOntology term extraction
   • GeneOntology shows low consistency (16.1%) in natural_to_code
     → Consider refining prompts for GeneOntology term extraction
   • MeSH shows low consistency (16.1%) in natural_to_code
     → Consider refining prompts for MeSH term extraction

CODE GENERATION CONSISTENCY ISSUES:
   • ontology_to_code shows low code similarity (7.3%)
     → Consider using lower temperature or more specific prompts
   • natural_to_code shows low code similarity (7.3%)
     → Consider using lower temperature or more specific prompts

GENERAL RECOMMENDATIONS:
   • Run more experiments (5+ runs) for better statistical significance
   • Monitor consistency trends over time
   • Consider prompt engineering if consistency is below 70%
   • Archive low-performing experiment configurations

================================================================================
End of Analysis Report
================================================================================